Wall BMY - Bristol-Myers Squibb
Annual data, 1996 to 2026, in US$ millions.
Last updated: Oct 3, 2026
Capital
Dividend
Revenue
Income
Asset
Equity
Rolling CAGR% per year, window ending each year
Other companies
Vertex Pharmaceuticals
Data since 1996
Sanofi
Data since 2001
GSK plc
Data since 1996
Pfizer
Data since 1996
Novo Nordisk
Data since 1996
WuXi AppTec
Data since 2014
Moderna
Data since 2016
Regeneron Pharmaceuticals
Data since 1996
Gilead Sciences
Data since 1996
Amgen
Data since 1996
AstraZeneca
Data since 1996
Novartis
Data since 1998
Roche
Data since 1998
Merck
Data since 1996
AbbVie
Data since 2010
Johnson & Johnson
Data since 1996
Eli Lilly
Data since 1996
CVS Health
Data since 1996
Thermo Fisher Scientific
Data since 1996
Prologis
Data since 1997
Cloudflare
Data since 2017
Intesa Sanpaolo
Data since 2003
Investor AB
Data since 2002
ASE Group
Data since 2000
Keyence
Data since 2005
Marathon Petroleum
Data since 2008
Booking Holdings (Booking.com)
Data since 1999
Parker-Hannifin
Data since 1996
Compagnie Financière Richemont
Data since 2002
Air Liquide
Data since 2003
2026 is partial: Capital is the current value; Revenue and Income are TTM; Asset and Equity are the latest quarter reported. CAGR runs through 2026. Rolling CAGR needs positive values at both ends of the window. Dividend = yield × Capital (approximate). Orange bars mark years that fell from the prior year. Y axes are log scale, so zero or negative values are not shown. Relative mode divides each series by its first positive value (capped at 500x, 1000x or 3000x, depending on the button); Absolute shows real values.